Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors
- 1 January 2002
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 55 (1) , 14-16
- https://doi.org/10.1136/jcp.55.1.14
Abstract
Aims: Ductal carcinoma in situ (DCIS) of the breast has been diagnosed increasingly since the advent of mammographic screening. In contrast to the situation in invasive breast carcinoma, there are no reports on androgen receptor (AR) status in DCIS and few reports on oestrogen (ER) and progesterone (PR) receptors. Methods: AR expression was examined in 57 cases of DCIS of the breast and correlated to the degree of differentiation and ER/PR status using immunohistochemical methods. Results: AR positivity was noted in 19 of the cases, whereas the other 38 cases were negative. There was no significant association between AR expression and the degree of differentiation of DCIS; three of the 13 well differentiated DCIS cases, 10 of the 19 intermediately differentiated cases, and six of the 25 poorly differentiated cases were positive (p = 0.093). However, a strong association was shown between the expression of ER (p < 0.0001) and PR (p = 0.002) and the degree of differentiation of DCIS. In addition, no significant association was found between the expression of AR and the expression of ER (p = 0.26) or PR (p = 0.57) in DCIS of the breast. Conclusions: A large number of cases of DCIS of the breast express AR and this may be associated with apocrine differentiation, which may impact on accurate typing of DCIS. Moreover, the expression of AR (but not ER or PR) in DCIS does not appear to be associated with the degree of differentiation.Keywords
This publication has 21 references indexed in Scilit:
- Ductal carcinoma in situ: a proposal for a new classification.1994
- Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissuesThe Journal of Pathology, 1994
- Ductal carcinoma in situ of the breast. Heterogeneity of individual lesionsCancer, 1994
- Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line.1993
- Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoproteinBritish Journal of Cancer, 1993
- Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factorsThe Journal of Pathology, 1993
- Effects of Androgens on Proliferation and Progesterone Receptor Levels in T47D Human Breast Cancer CellsTumor Biology, 1993
- Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptorBreast Cancer Research and Treatment, 1993
- Receptors for estrogen and progesterone in breast carcinoma in situ.1992
- IMMUNOCYTOCHEMICAL LOCALIZATION OF ESTROGEN AND PROGESTERONE-RECEPTOR AND PROGNOSIS IN HUMAN PRIMARY BREAST-CANCER1990